4//SEC Filing
McDowell Glenn 4
Accession 0001209191-17-049905
CIK 0000885978other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 1:47 PM ET
Size
7.7 KB
Accession
0001209191-17-049905
Insider Transaction Report
Form 4
McDowell Glenn
Chief Operating Officer
Transactions
- Sale
Common Stock
2017-08-21$60.01/sh−1,064$63,851→ 33,434 total - Sale
Common Stock
2017-08-22$59.72/sh−600$35,832→ 32,834 total
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00- $60.05, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.70- $59.80, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
U S PHYSICAL THERAPY INC /NV
CIK 0000885978
Entity typeother
Related Parties
1- filerCIK 0001315304
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 1:47 PM ET
- Size
- 7.7 KB